TMCnet News

Next Generation Sequencing (NGS), Segment Patent Overview 2011-2016 - Research and Markets
[August 24, 2016]

Next Generation Sequencing (NGS), Segment Patent Overview 2011-2016 - Research and Markets


Research and Markets has announced the addition of the "Next Generation Sequencing (NGS), Segment - Patent Overview in the years 2011 - 2016" report to their offering.

Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionized genomic research. The instruments and consumables are the largest segments with a share of around half of the market in 2013.

The fastest growing segment is the services with the highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents.

The major players operatin in the NGS segment are Illumina Inc (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences (U.S.) Agilent (News - Alert) Technologies (U.S.), BGI (Beijing Genomics Institute) (China), Qiagen (Netherlands), Biomatters Ltd (New Zealand), and Genomatix Software GmbH (Germany).



All major companies are investing profoundly in new product development to keep up with competition and so there are "n" number of innovations in the form of patents.

Key Topics Covered:


1. Objective

2. Overview

3. Search Strategy

4. Patent set segmentation

5. Categorization Tree

6. IP Publication Trend

7. Top 10 Assignees Graph

8. Research Breadth across various jurisdictions: Key Statistics

9. White Space Matrix (Technology)

10. Legal Status Graph

11. Summary

For more information about this report visit http://www.researchandmarkets.com/research/j5dcx5/next_generation

Related Topics: Molecular Diagnostics


[ Back To TMCnet.com's Homepage ]